The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loyer, V.
Right arrow Articles by Perreault, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loyer, V.
Right arrow Articles by Perreault, C.
The Journal of Immunology, 1999, 163: 6462-6467.
Copyright © 1999 by The American Association of Immunologists

The In Vivo Fate of APCs Displaying Minor H Antigen and/or MHC Differences Is Regulated by CTLs Specific for Immunodominant Class I-Associated Epitopes1

Véronique Loyer, Pierre Fontaine, Stéphane Pion, Francis Hétu, Denis-Claude Roy and Claude Perreault2

Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

The goal of this work was to evaluate the fate of APCs following interactions with T cells in unprimed mice with a normal T cell repertoire. We elaborated a model in which male adherent peritoneal mononuclear cells were injected into the foreleg footpads of naive female recipients mismatched for either minor or major histocompatibility Ags. At various times after injection, APC numbers in the draining (axillary and brachial) lymph nodes were assessed using a Ube1y gene-specific PCR assay. Our experimental model was designed so that the number of APCs expressing the priming epitope was similar to what is observed under real life conditions. Thus, early after injection, the frequency of afferent lymph-derived APCs expressing the priming epitope was in the range of 101–102/106 lymph node cells. We found that APCs presenting some, but not all, nonself epitopes were killed rapidly after entrance into the lymph nodes. Rapid elimination of APCs occurred following interactions with MHC class I-restricted, but not class II-restricted, T cells and was observed when APCs presented an immunodominant (B6dom1/H7a), but not a nondominant (HY), epitope. Killing of APCs was mediated partly, but not exclusively, by perforin-dependent process. We propose that killing of APCs by CTLs specific for immunodominant MHC class I-restricted epitopes may be instrumental in regulating the intensity, duration, and diversity of T cell responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Luketic, J. Delanghe, P. T. Sobol, P. Yang, E. Frotten, K. L. Mossman, J. Gauldie, J. Bramson, and Y. Wan
Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL
J. Immunol., October 15, 2007; 179(8): 5024 - 5032.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Baron, M.-C. Meunier, E. Caron, C. Cote, M. J. Cameron, D. J. Kelvin, R. LeBlanc, V. Rineau, and C. Perreault
Asynchronous Differentiation of CD8 T Cells That Recognize Dominant and Cryptic Antigens
J. Immunol., December 15, 2006; 177(12): 8466 - 8475.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Laffont, J. D. Coudert, L. Garidou, L. Delpy, A. Wiedemann, C. Demur, C. Coureau, and J.-C. Guery
CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo
Blood, October 1, 2006; 108(7): 2257 - 2264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. N. Mueller, C. M. Jones, A. T. Stock, M. Suter, W. R. Heath, and F. R. Carbone
CD4+ T Cells Can Protect APC from CTL-Mediated Elimination.
J. Immunol., June 15, 2006; 176(12): 7379 - 7384.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Mayerova, L. Wang, L. S. Bursch, and K. A. Hogquist
Conditioning of langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo.
J. Immunol., April 15, 2006; 176(8): 4658 - 4665.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yang, S. P. Huck, R. S. McHugh, I. F. Hermans, and F. Ronchese
Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo
PNAS, January 3, 2006; 103(1): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Newberg, K. J. McEvers, D. A. Gorgone, M. A. Lifton, S. H. C. Baumeister, R. S. Veazey, J. E. Schmitz, and N. L. Letvin
Immunodomination in the Evolution of Dominant Epitope-Specific CD8+ T Lymphocyte Responses in Simian Immunodeficiency Virus-Infected Rhesus Monkeys
J. Immunol., January 1, 2006; 176(1): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Yamaoka, B. Min, Y.-J. Zhou, W. E. Paul, and J. J. O'Shea
Jak3 negatively regulates dendritic-cell cytokine production and survival
Blood, November 1, 2005; 106(9): 3227 - 3233.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
R. Obst, H.-M. van Santen, D. Mathis, and C. Benoist
Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
J. Exp. Med., May 16, 2005; 201(10): 1555 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. M. Jelley-Gibbs, J. P. Dibble, S. Filipson, L. Haynes, R. A. Kemp, and S. L. Swain
Repeated stimulation of CD4 effector T cells can limit their protective function
J. Exp. Med., April 4, 2005; 201(7): 1101 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Gorbachev and R. L. Fairchild
CD4+ T Cells Regulate CD8+ T Cell-Mediated Cutaneous Immune Responses by Restricting Effector T Cell Development through a Fas Ligand-Dependent Mechanism
J. Immunol., February 15, 2004; 172(4): 2286 - 2295.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. E. Hirst, M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird
The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency
J. Immunol., January 15, 2003; 170(2): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Chen, J. R. Bennink, P. A. Morton, and J. W. Yewdell
Mice Deficient in Perforin, CD4+ T Cells, or CD28-Mediated Signaling Maintain the Typical Immunodominance Hierarchies of CD8+ T-Cell Responses to Influenza Virus
J. Virol., September 11, 2002; 76(20): 10332 - 10337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. C. Probst, T. Dumrese, and M. F. van den Broek
Cutting Edge: Competition for APC by CTLs of Different Specificities Is Not Functionally Important During Induction of Antiviral Responses
J. Immunol., June 1, 2002; 168(11): 5387 - 5391.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. P. Medema, D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E.M. Toes, M. Toebes, T. N.M. Schumacher, et al.
Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte-induced Apoptosis: Differential Modulation by T Helper Type 1 and Type 2 Cells
J. Exp. Med., September 4, 2001; 194(5): 657 - 668.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
F. Ronchese and I. F. Hermans
Killing of Dendritic Cells: A Life Cut Short or a Purposeful Death?
J. Exp. Med., September 4, 2001; 194(5): F23 - F26.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E. Y. Choi, Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian
Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others
J. Immunol., April 1, 2001; 166(7): 4370 - 4379.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.